Brief: ALK-Abello Says Neffy Approved In Canada
April 15 (Reuters) - ALK-Abello A/S ALKb.CO: NEFFY APPROVED AS FIRST NEEDLE-FREE ANAPHYLAXIS TREATMENT OF ADULTS AND CHILDREN IN CANADA HEALTH CANADA APPROVES NEFFY 2 MG FOR EMERGENCY ANAPHYLAXIS TREATMENT IN ADULTS AND CHILDREN APPROVAL DOES NOT AFFECT CO'S FINANCIAL GUIDANCE FOR 2026 Source text: ID:nGNE90Nj4V Further company coverage: [ALKb.CO] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))